EligibleTrials

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

Recruiting · NCT06214598 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Belgrade

View the official record on ClinicalTrials.gov →
Breast Cancer

Interventions studied

AI dietPlaceboSupplement

What this trial is about

This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.

Who can take part

Age range
45 Years to 70 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.